The difficulties industry is facing with investigators

European Journal of Cancer

Volumn 41, Issue 15, 2005, Pages 2210-2212

  Blackledge, George R P ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Drug development; Industry; Institutes; Investigators

Indexed keywords

ANTINEOPLASTIC AGENT;

ANOREXIA; CANCER RESEARCH; CLINICAL PRACTICE; CONSTIPATION; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DYSPNEA; FATIGUE; HUMAN; INSOMNIA; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW;

EID: 26244456088     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.11.020     Document Type: Article

References (3)

1. Z. Kmietowicz British cancer death rates fell by 12% between 1972 and 2002 Brit Med J 328 2004 303
2. Harris Interactive Inc.; 2000.
3. E.K. Fromme, K.M. Eilers, and M. Mori How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30 J Clin Oncol 22 17 2004 3485 3490